32 C
Vientiane
Monday, October 20, 2025
spot_img

Cision PR Newswire

The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC

After a median follow-up of 18.9 months, the median PFS was 8.3 months in the sac-TMT group and 4.3 months in the chemotherapy...

Applications Now Open for the 7th Guangzhou Award

SEOUL, South Korea, Sept. 29, 2025 /PRNewswire/ -- On September 29, the launch ceremony of the 7th Guangzhou International Award for Urban Innovation (Guangzhou Award)...

Eagle Eye Unveils Smart Rewards, A Real-Time Omnichannel Loyalty and Incentive Solution for Retailers

New real-time personalization execution solution from the leaders in retail loyalty technology instantly creates rewarding customer experiences when they matter most LONDON, Sept....

Makera Z1 Makes Global Debut at IFA 2025, Wins Innovation Award, and Sets Stage for Kickstarter Launch

Entry-Level CNC. Pro-Level Power. MIDDLETOWN, Del., Sept. 29, 2025 /PRNewswire/ -- Makera, the pioneer in smart desktop CNC solutions, took center stage at IFA 2025...